For many with Huntington’s disease, recognising faces, navigating familiar places, or reading can be difficult. Scientists studied how and when HD affects how the brain processes what we see—crucial ...

Imagine a busy intersection - traffic is carefully orchestrated with different colored lights, telling drivers when to stop and when to go. If a signal turns yellow, drivers know that the light is in ...

Hidden twists in the Huntington’s disease gene could shift symptoms by over a decade! Scientists have uncovered rare “genetic dams” that shape when HD begins - sometimes dramatically ...

Votoplam belongs to a class of drugs known as splice modulators. The drug can be taken as a daily pill - a convenient and non-invasive method of delivery. The drug is a chemical that changes how the ...

Dr. Sarah Hernandez is the Director of Research Programs at the Hereditary Disease Foundation (HDF). She carried out her ...

Huntington’s disease research news. In plain language. Written by scientists. For the global HD community. This is a fallback page – if you see it something has gone wrong – email [email protected] with ...

A new study shows that lowering MSH3, a key DNA repair protein, with antisense oligonucleotide (ASO) therapy can stop CAG repeat expansions in HD patient-derived brain cells. This could be a promising ...